The state of Kansas has passed Bill 2280 allowing health care providers to prescribe off-label medications for early treatment of COVID-19. This bill prevents disciplinary action against those prescribing medications such as ivermectin, hydroxychloroquine, and fluvoxamine. Senator Dr. Mark Steffen has written a letter to health care providers across the state reminding them of this new legislation. Bill 2280 offers more options to help clinicians provide safe and effective early treatments. Dr. Steffen notes that delaying treatment worsens patient outcomes and failure to treat is not acceptable.
Dr. Stephen Pelech provides an end of year review of the science that supports or refutes the public health policies imposed during the COVID-19 crisis.